-
EP3917921
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP3917921
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2011062906
[A] (ELLIOT GARY T et al.) | Type: | Non-patent literature | Publication information: | [A] CHEN WEIHAI ET AL: "Characteristics of hERG and hNav1.5 channel blockade by sulcardine sulfate, a novel anti-arrhythmic compound", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 844, 6 December 2018 (2018-12-06), pages 130 - 138, XP085575601, ISSN: 0014-2999, DOI: 10.1016/J.EJPHAR.2018.12.009 | DOI: | http://dx.doi.org/10.1016/j.ejphar.2018.12.009 | Type: | Non-patent literature | Publication information: | [A] LU YOU-LI ET AL: "Oral Bioavailability and Mass Balance Studies of a Novel Anti-arrhythmic Agent Sulcardine Sulfate in Sprague-Dawley Rats and Beagle Dogs", EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, EDITIONS MEDECINE ET HYGIENE, CHENE-BOURG, CH, vol. 42, no. 3, 11 July 2016 (2016-07-11), pages 453 - 459, XP036231628, ISSN: 0378-7966, [retrieved on 20160711], DOI: 10.1007/S13318-016-0360-3 | DOI: | http://dx.doi.org/10.1007/s13318-016-0360-3 | Cited in | by applicant | Type: | Patent literature | Publication No.: | US8541464
| Type: | Patent literature | Publication No.: | US8637566
| Type: | Patent literature | Publication No.: | US6605635
| Type: | Patent literature | Publication No.: | US16712677
| Type: | Non-patent literature | Publication information: | LEEWEB, PHARMACEUTICAL ANALYSIS, 2003, pages 255 - 257 | Type: | Non-patent literature | Publication information: | GIBALDI MPERRIER D.: "Pharmacokinetics", 1982, MARCEL DEKKER, INC., pages: 409 - 17 | Type: | Non-patent literature | Publication information: | MASON ET AL., CIRCULATION, vol. 140, 2019, pages A11495 |